Anti-neoplastic therapy refers to the therapy which aims to prevent, inhibit or halt the development of a neoplasm.
This report contains market size and forecasts of Anti-Neoplastic Therapy in Global, including the following market information:
Global Anti-Neoplastic Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anti-Neoplastic Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Chemotherapeutic Agents Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti-Neoplastic Therapy include Amgen Inc., AstraZeneca plc, Bayer AG, Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company and Teva Pharmaceutical Industries Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-Neoplastic Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Neoplastic Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anti-Neoplastic Therapy Market Segment Percentages, by Type, 2021 (%)
Chemotherapeutic Agents
Immunotherapeutic Agents
Personalized Medicine
Global Anti-Neoplastic Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anti-Neoplastic Therapy Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Cancer Rehabilitation Centers
Ambulatory Surgical Centers
Global Anti-Neoplastic Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anti-Neoplastic Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Neoplastic Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anti-Neoplastic Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen Inc.
AstraZeneca plc
Bayer AG
Johnson & Johnson
Merck & Co., Inc.
Pfizer Inc.
F. Hoffmann-La Roche Ltd.
Eli Lilly and Company
Teva Pharmaceutical Industries Ltd.
Boehringer Ingelheim
Aspen Pharmacare Holdings Limited
AbbVie Inc.